HAK Clone 7 Cell Line

This cell line is a non-cancerous human oral keratinocyte. Maintains normal phenotype in culture, diploid. This clone exhibits loss of p16INK4a expression.

Contributors

Inventor Institute
Aloysius Klingelhutz The University of Iowa
Cat. #: 154468
Unit size: 1×10^6 cells / vial
Cancer types: Head and neck cancer
Research Fields: Cancer
Organism: Human
Tissue: Adenoid
Model: Immortalised non-cancerous cell line
Cancer Types In Detail: Head;Neck;Oral
Alternate name: hTERT HAK Clone 7; human adenoid epithelial cells
Product description: This cell line is a non-cancerous human oral keratinocyte. Maintains normal phenotype in culture, diploid. This clone exhibits loss of p16INK4a expression.
Conditional: No
disease: Cancer
Format: Frozen
Shipping conditions: Dry ice
References:

Farwell et al. 2000. Am J Pathol. 156(5):1537-47. PMID: 10793065.

Related Tools for Cell lines

Cat. # Tool Name
151450 JIM3 Cell Line Key Info View Tool
151579 U-2 OS Gal4-p300 Cell Line Key Info View Tool
151626 A375P beta6-puro Cell Line Key Info View Tool
151629 MEF Raf1 FF/FF KI Cell Line Key Info View Tool
151631 C-Raf KI D486A Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.